Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New England Cannabis Corporation was a Massachusetts-based cannabis cultivation and product manufacturing company operating from Holliston, Massachusetts. The company held Massachusetts Cannabis Control Commission licenses for indoor Tier 4 cultivation and product manufacturing, and ran a fully operational cultivation facility with approximately 55,000 square feet of infrastructure. In October 2021, 4Front Ventures announced an agreement to acquire the company, and the transaction closed in January 2022 for total consideration reported at approximately $55 million. The business appears to have been focused on commercial-scale cannabis flower production and related manufactured cannabis products rather than traditional biopharma drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New England Cannabis Corporation.